Method of variability optimization in pharmacokinetic data analysis

被引:6
|
作者
Grabowski, Tomasz [1 ]
Jaroszewski, Jerzy Jan [2 ]
Piotrowski, Walerian [3 ]
Sasinowska-Motyl, Magorzta [4 ]
机构
[1] Polpharma Biol, PL-80172 Gdansk, Poland
[2] Univ Warmia & Mazury, Dept Pharmacol & Toxicol, Fac Vet Med, PL-10718 Olsztyn, Poland
[3] Inst Cardiol, Dept Epidemiol Cardiovasc Dis Prevent & Hlth Prom, Biostat Lab, Warsaw, Poland
[4] Med Univ Warsaw, Dept Pharmacodynam, PL-00927 Warsaw, Poland
关键词
Standard deviation; Sampling; Variability; Pharmacokinetics; HIGHLY VARIABLE DRUGS; STANDARD-DEVIATION; PHARMACODYNAMICS; ABSORPTION; COMPOUND;
D O I
10.1007/s13318-013-0145-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For many drugs administered per os, high variability in the concentration-time (C-T) values from first sampling to the phase of distribution may cause difficulty in pharmacokinetic analysis. Therefore, the aim of this study was to propose a method of transformation of C-T data, which would allow significantly reducing the standard deviation (SD) value of observed concentrations, without a statistically significant influence on the value of the mean for each sampling point in group. In the presented study, the lowest value of relative standard deviation of concentrations observed in the elimination phase and the value of precision of the used analytical method, were used to optimize the arithmetic, geometric means, median, and the value of SD obtained after single oral administration of itraconazole in human subjects. Non-compartmental modeling was used to estimate pharmacokinetic parameters. The analysis of SD pharmacokinetic parameters after C-T value optimization indicated more than twice the lower value of SD. After transforming the itraconazole data, lower variability of concentration data gives more selective pharmacokinetics profile in absorption and early distribution phase.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 50 条
  • [21] Analysis of population pharmacokinetic data using NONMEM and WinBUGS
    Duffull, SB
    Kirkpatrick, CMJ
    Green, B
    Holford, NHG
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2005, 15 (01) : 53 - 73
  • [22] Inflammation: Planning for a Source of Pharmacokinetic/Pharmacodynamic Variability in Translational Studies
    Schmith, V. D.
    Foss, J. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (04) : 488 - 491
  • [24] Population pharmacokinetic analysis of mizolastine and validation from sparse data on patients using the nonparametric maximum likelihood method
    Mesnil, F
    Mentre, F
    Dubruc, C
    Thenot, JP
    Mallet, A
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1998, 26 (02): : 133 - 161
  • [25] Pharmacokinetic variability and apparent drug resistance
    Adamson, PC
    Poplack, DG
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1997, 4 (06): : 525 - 530
  • [26] EXPLORING SIROLIMUS PHARMACOKINETIC VARIABILITY USING DATA AVAILABLE FROM THE ROUTINE CLINICAL CARE OF RENAL TRANSPLANT PATIENTS - POPULATION PHARMACOKINETIC APPROACH
    Golubovic, Bojana
    Vucicevic, Katarina
    Radivojevic, Dragana
    Kovacevic, Sandra Vezmar
    Prostran, Milica
    Miljkovic, Branislava
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2019, 38 (03) : 323 - 331
  • [27] Population Pharmacokinetic Analysis of Mizolastine and Validation from Sparse Data on Patients Using the Nonparametric Maximum Likelihood Method
    Florence Mesnil
    France Mentré
    Catherine Dubruc
    Jean-Paul Thénot
    Alain Mallet
    Journal of Pharmacokinetics and Biopharmaceutics, 1998, 26 : 133 - 161
  • [28] Pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology
    Agesen, Frederik N.
    Weeke, Peter E.
    Tfelt-Hansen, Peer
    Tfelt-Hansen, Jacob
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2019, 7 (04):
  • [29] Markov chain Monte Carlo techniques for studying interoccasion and intersubject variability: Application to pharmacokinetic data
    Lunn, DJ
    Aarons, LJ
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 1997, 46 (01) : 73 - 91
  • [30] Update on clindamycin: New pharmacokinetic and pharmacodynamic data
    Lewis, RE
    Klepser, ME
    INFECTIONS IN MEDICINE, 1998, 15 (10) : 726 - 731